insights_auto
Why is EDIT down 4,09%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,64 $
arrow_downward
-4,09%(-0,070) 1D
1,66 $
arrow_upward
+1,22% (+0,020)bedtimeAfter hours
Closed: 20 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,69 $
High
1,78 $
Low
1,63 $
Mkt. cap
253,12 մլն
Avg. vol.
2,24 մլն
Volume
2,68 մլն
52-wk high
3,94 $
52-wk low
1,63 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Trefis
·
22 րոպե առաջ
25 S&P 500 Stocks Just Made New 52-Week Lows
Chattanooga Times Free Press
·
37 րոպե առաջ
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
Traders Union
·
2 ժամ առաջ
VIX fear index hits highest level since April 2025 as S&P 500 plunges
BigGo Finance
·
3 ժամ առաջ
S&P 500 Falls for Seventh Straight Session, Enters Correction as AI Stock Rally Loses Steam
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc